Pure Global

Bio-Rad Seraclone Anti-Lea (LE1) and Leb (LE2) - HSA Registration DE0503626

Access comprehensive regulatory information for Bio-Rad Seraclone Anti-Lea (LE1) and Leb (LE2) in the Singapore medical device market through Pure Global AI's free database. This CLASS C IVD medical device is registered under HSA registration number DE0503626 and owned by Bio-Rad Medical Diagnostics GmbH. The device was registered on September 23, 2019.

This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.

Free Database
Powered by Pure Global AI
HSA Official Data
CLASS C IVD
DE0503626
Bio-Rad Seraclone Anti-Lea (LE1) and Leb (LE2)
HSA Registration Number: DE0503626
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Product Description

It is used for the determination of the Lea and Leb antigen of red blood cells using the tube test.

Device Classification
Device Class
CLASS C IVD
Medical Speciality Area
Immunology
Registration Information
Registration Number
DE0503626
Registration Date
September 23, 2019
Change Notification Approval Date
June 17, 2021
Retention Due Date
September 22, 2025
Product Owner
Short Name
Bio-Rad Medical Diagnostics GmbH
Address
Industriestr. 1, 63303 Dreieich, Deutschland, GERMANY
Registrant
Address
3A INTERNATIONAL BUSINESS PARK, ICON@IBP, #11-10/16, SINGAPORE 609935
Importer
Address
3A INTERNATIONAL BUSINESS PARK, ICON@IBP, #11-10/16, SINGAPORE 609935
Model Information
Model Name(s)
Seraclone Anti-Lea (LE1) Seraclone Anti-Leb (LE2)
Model Identifier(s)
808404 808423